{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:13:58Z","timestamp":1792451638923,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-025-01446-y","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T20:32:09Z","timestamp":1767817929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3253-232X","authenticated-orcid":false,"given":"Domitilla","family":"Baccon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3380-5326","authenticated-orcid":false,"given":"Suheil Albert","family":"Atallah-Yunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1292-3024","authenticated-orcid":false,"given":"Paul J.","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey E.","family":"Roeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2767-3830","authenticated-orcid":false,"given":"Saad S.","family":"Kenderian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2210-2174","authenticated-orcid":false,"given":"Eli","family":"Muchtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5951-5055","authenticated-orcid":false,"given":"Neil E.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber B.","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Behnken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine C.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6955-9393","authenticated-orcid":false,"given":"Grzegorz S.","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3532-9132","authenticated-orcid":false,"given":"Thomas M.","family":"Habermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8249-4128","authenticated-orcid":false,"given":"Talal","family":"Hilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazie","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose F.","family":"Leis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison C.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9314-9933","authenticated-orcid":false,"given":"Ricardo D.","family":"Parrondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han W.","family":"Tun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-4293","authenticated-orcid":false,"given":"Min","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-8163","authenticated-orcid":false,"given":"Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3221-7314","authenticated-orcid":false,"given":"Sameer A.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1576-8341","authenticated-orcid":false,"given":"Yucai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"1446_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/ajcp\/93.1.117","volume":"93","author":"KM Bayliss","year":"1990","unstructured":"Bayliss KM, Kueck BD, Hanson CA, Matthaeus WG, Almagro UA. Richter\u2019s syndrome presenting as primary central nervous system lymphoma. Transformation of an identical clone. Am J Clin Pathol. 1990;93:117\u201323.","journal-title":"Am J Clin Pathol"},{"key":"1446_CR2","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.3109\/10428194.2013.765565","volume":"54","author":"P Jain","year":"2013","unstructured":"Jain P, Benjamini O, Pei L, Caraway NP, Landon G, Kim S, et al. Central nervous system Richter\u2019s transformation and parvovirus B19 infection. Leuk lymphoma. 2013;54:2070\u20132.","journal-title":"Leuk lymphoma"},{"key":"1446_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/ajcp\/89.2.254","volume":"89","author":"PK Lane","year":"1988","unstructured":"Lane PK, Townsend RM, Beckstead JH, Corash L. Central nervous system involvement in a patient with chronic lymphocytic leukemia and non-Hodgkin\u2019s lymphoma (Richter\u2019s syndrome), with concordant cell surface immunoglobulin isotypic and immunophenotypic markers. Am J Clin Pathol. 1988;89:254\u20139.","journal-title":"Am J Clin Pathol"},{"key":"1446_CR4","doi-asserted-by":"publisher","first-page":"e12701","DOI":"10.1097\/MD.0000000000012701","volume":"97","author":"L Xu","year":"2018","unstructured":"Xu L, Song JC, Sun XH, Gao ZF, Lv L, Zhu J. Richter\u2019s syndrome of the central nervous system diagnosed concurrently with chronic lymphocytic leukaemia: a case report and literature review. Medicine. 2018;97:e12701.","journal-title":"Medicine"},{"key":"1446_CR5","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2141.2010.08238.x","volume":"150","author":"JM Calvo-Villas","year":"2010","unstructured":"Calvo-Villas JM, Fern\u00e1ndez JA, de la Fuente I, Godoy AC, Mateos MC, Poder\u00f3s C. Intrathecal liposomal cytarabine for treatment of leptomeningeal involvement in transformed (Richter\u2019s syndrome) and non-transformed B-cell chronic lymphocytic leukaemia in Spain: a report of seven cases. Br J Haematol. 2010;150:618\u201320.","journal-title":"Br J Haematol"},{"key":"1446_CR6","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1182\/blood.2023020168","volume":"142","author":"JP Alderuccio","year":"2023","unstructured":"Alderuccio JP, Nayak L, Cwynarski K. How I treat secondary CNS involvement by aggressive lymphomas. Blood. 2023;142:1771\u201383.","journal-title":"Blood"},{"key":"1446_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/hon.3148","volume":"41","author":"J Khwaja","year":"2023","unstructured":"Khwaja J, Cwynarski K. Management of primary and secondary CNS lymphoma. Hematol Oncol. 2023;41:25\u201335.","journal-title":"Hematol Oncol"},{"key":"1446_CR8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3324\/haematol.2022.281640","volume":"108","author":"J Khwaja","year":"2023","unstructured":"Khwaja J, Kirkwood AA, Isbell LK, Steffanoni S, Goradia H, Pospiech L, et al. International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma. Haematologica. 2023;108:882\u20138.","journal-title":"Haematologica"},{"key":"1446_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3324\/haematol.2021.278613","volume":"109","author":"M Roschewski","year":"2024","unstructured":"Roschewski M, Hodson DJ. Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy. Haematologica. 2024;109:388\u2013400.","journal-title":"Haematologica"},{"key":"1446_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/bjh.14177","volume":"175","author":"TA Eyre","year":"2016","unstructured":"Eyre TA, Clifford R, Bloor A, Boyle L, Roberts C, Cabes M, et al. NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome. Br J Haematol. 2016;175:43\u201354.","journal-title":"Br J Haematol"},{"key":"1446_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01236-6","volume":"15","author":"AS Kittai","year":"2025","unstructured":"Kittai AS, Huang Y, Miller S, Allan JN, Bhat SA, Bond DA, et al. Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL. Blood Cancer J. 2025;15:23.","journal-title":"Blood Cancer J"},{"key":"1446_CR12","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3324\/haematol.2019.224121","volume":"105","author":"Y Wang","year":"2020","unstructured":"Wang Y, Tschautscher MA, Rabe KG, Call TG, Leis JF, Kenderian SS, et al. Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center. Haematologica. 2020;105:765\u201373.","journal-title":"Haematologica"},{"key":"1446_CR13","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/10428194.2020.1719092","volume":"61","author":"Y Ben-Dali","year":"2020","unstructured":"Ben-Dali Y, Hleuhel MH, da Cunha-Bang C, Brieghel C, Poulsen CB, Clasen-Linde E, et al. Richter\u2019s transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study. Leuk lymphoma. 2020;61:1435\u201344.","journal-title":"Leuk lymphoma"},{"key":"1446_CR14","doi-asserted-by":"publisher","first-page":"LBA-3-LBA-","DOI":"10.1182\/blood-2022-171733","volume":"140","author":"G Illerhaus","year":"2022","unstructured":"Illerhaus G, Ferreri AJ, Binder M, Borchmann P, Hasenkamp J, Stilgenbauer S, et al. Effects on survival of non-myeloablative chemoimmunotherapy compared to high-dose chemotherapy followed by autologous stem cell transplantation (HDC-ASCT) as consolidation therapy in patients with primary CNS lymphoma-results of an international randomized phase III trial (MATRix\/IELSG43). Blood. 2022;140:LBA-3-LBA-.","journal-title":"Blood"},{"key":"1446_CR15","doi-asserted-by":"publisher","first-page":"12146","DOI":"10.1182\/blood-2022-170703","volume":"140","author":"H Narvel","year":"2022","unstructured":"Narvel H, Vegivinti CTR, Vikash S, Bazarbachi A-H, Wang S, Reef DK, et al. Autologous stem cell transplantation (ASCT) improves survival outcome in primary central nervous system lymphoma (PCNSL) in a minority rich, underserved inner city population in the real-world setting. Blood. 2022;140:12146\u20137.","journal-title":"Blood"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01446-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01446-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01446-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T20:32:10Z","timestamp":1767817930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01446-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1446"],"URL":"https:\/\/doi.org\/10.1038\/s41408-025-01446-y","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DB: declares no conflicts of interest. PJH:\n                      Research funding\n                      (to institution): BeOne, AstraZeneca.\n                      Consultancy and Honorarium\n                      (compensation to the institution): AbbVie. LER:\n                      Consulting\n                      : AbbVie, Ascentage, AstraZeneca, Beigene, Janssen, Loxo Oncology, Pharmacyclics;\n                      Data safety monitoring committee (DSMC) member\n                      : Ascentage; CME speaker: DAVA, Curio, Medscape, and PeerView;\n                      Minority ownership interest\n                      : Abbott Laboratories; Travel support: LOXO oncology,\n                      Research funding\n                      (to institution): Adaptive Biotechnologies, AstraZeneca, Genentech, AbbVie, Pfizer, Loxo Oncology, Aptose Biosciences, Dren Bio, and Qilu Puget Sound Biotherapeutics. NEK:\n                      Advisory Board for\n                      : AbbVie, Astra Zeneca, Beigene, Janssen, Pharmacyclics,\n                      DSMC\n                      (Data Safety Monitoring Committee) for: AstraZeneca, BMS-Celgene, Dren Bio,\n                      Research funding\n                      : AbbVie, Acerta Pharma, Astra Zeneca, Pharmacyclics\/Jannsen, Merck. TH:\n                      Research funding\n                      (to institution): BeiGene, BMS; Advisory Board: BeiGene. SAP:\n                      Research funding\n                      : Janssen, AstraZeneca, Merck, and Genentech for clinical studies in which Sameer A. Parikh is a principal investigator.\n                      Honoraria\n                      : Pharmacyclics, Merck, AstraZeneca, Janssen, BeiGene, Genentech, SoBi, MingSight Pharmaceuticals, Novalgen Limited, Kite Pharma, and AbbVie for Sameer A. Parikh\u2019s participation in consulting activities\/advisory board meetings. YW:\n                      Research funding\n                      (to institution): Incyte, InnoCare, LOXO Oncology, Eli Lilly, MorphoSys, Novartis, Genentech, Genmab, AbbVie, BeiGene, Merck;\n                      Advisory board\n                      (compensation to institution): Eli Lilly, LOXO Oncology, TG Therapeutics, Incyte, InnoCare, Kite, Jansen, BeiGene, AstraZeneca, Genmab, AbbVie;\n                      Consultancy\n                      (compensation to institution): InnoCare, AbbVie; Honorarium (to institution): Kite.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Mayo Clinic Institutional Review Board. The study was conducted in compliance with the Declaration of Helsinki. Given the retrospective nature of the study, a waiver of consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"7"}}